Brief: Modern Chinese Medicine Group Sees Fall In Profit Attributable From 40% To 50% For 2023 1H
Aug 18 (Reuters) - Modern Chinese Medicine Group Co Ltd
1643.HK :
* SEES FALL IN PROFIT ATTRIBUTABLE RANGING FROM 40% TO 50%
FOR
2023 1H
* EXPECTED RESULT DUE TO RISE IN COSTS OF COMMONLY USED RAW
MATERIALS, AMONG OTHERS
Further company coverage: 1643.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Modern Chinese Medicine
See all newsBrief: Modern Chinese Medicine Expects Net Loss Of Rmb25.9 Million For Six Months
Brief: Modern Chinese Medicine To Buy 30% Stake In AI Health Global For HK$41.8 Million
Brief: Modern Chinese Medicine Expects Profit Of Not Less Than RMB2.0 Million For HY
Brief: Modern Chinese Medicine Says To Allot And Issue Aggregate Of 120 Mln Subscription Shares
Brief: Modern Chinese Medicine Sees Net Profit For 2024 Between RMB8.0 Million And RMB12.0 Million